Trump Announces IVF Drug Pricing Deal That Will Lower Costs

NBC NewsFriday, October 17, 2025 at 12:54:38 PM
PositiveHealth
Trump Announces IVF Drug Pricing Deal That Will Lower Costs

Trump Announces IVF Drug Pricing Deal That Will Lower Costs

President Donald Trump has announced a significant step towards making in vitro fertilization (IVF) more affordable by striking a deal with specialty pharmacies and a drug manufacturer to lower the cost of a commonly prescribed fertility drug. This initiative is crucial as it not only aims to reduce financial barriers for couples seeking IVF but also encourages employers to provide fertility benefits, making it easier for families to access necessary treatments. This move could have a positive impact on many individuals and couples looking to start or expand their families.
— via World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
White House strikes deals for lower prices on obesity drugs
PositiveHealth
The White House has announced new agreements that will allow Medicare beneficiaries to access obesity and Type 2 diabetes medications for just a $50 copay. This is a significant step towards making essential health treatments more affordable for millions of Americans, addressing a growing health crisis. However, it's important to note that there are some limitations to these deals, which could affect how many people can benefit from this initiative.
Trump unveils deal to expand coverage and lower costs on obesity drugs
PositiveHealth
President Donald Trump has announced a significant deal with drugmakers Eli Lilly and Novo Nordisk aimed at expanding coverage and lowering costs for obesity treatments like Zepbound and Wegovy. This move is crucial as it addresses the rising obesity rates and makes effective treatments more accessible to those in need, potentially improving health outcomes for millions.
Costs for Zepbound, Wegovy Could Drop Soon: What to Know
PositiveHealth
Great news for those struggling with weight loss! The White House is negotiating with the manufacturers of Wegovy and Zepbound to significantly reduce their prices from around $1,300 to just $150 a month. This could make these effective weight loss drugs much more accessible for many people. While eligibility details are still unclear, this move could potentially transform the landscape of weight management for countless individuals, making it easier for them to achieve their health goals.
White House nears deal to lower prices for weight loss drugs Wegovy and Zepbound
PositiveHealth
The White House is close to finalizing a deal with Eli Lilly and Novo Nordisk to reduce the prices of their popular weight loss drugs, Wegovy and Zepbound. This announcement is expected to come this week, bringing hope for more affordable options for those seeking weight management solutions.